Referral medical centers in the united states and canada. Pdf glycogen storage disorders are a group of inborn errors of metabolism characterized by accumulation of glycogen in various tissues. Andersen disease gsdiv also known as glycogen storage disease type iv. Glycogen serves as the primary fuel reserve for the bodys energy needs. In july 2018, he launched the worlds first human gene therapy clinical trial to. Mutations in the g6pc gene result in a deficiency in the glucose6phosphatase g6pase enzyme and account for. The hepatic glycogen storage diseases gsds are a group of inborn errors of metabolism caused by abnormalities of the enzymes that catalyze the synthesis or degradation of glycogen. Dietary management of the glycogen storage diseases. Glycogen storage disease in adults annals of internal. Background paper on glycogen storage disease glycogen storage disease gsd is the result of defects in the processing of glycogen synthesis or breakdown within muscles, liver, and other cell types. Table i summarizesthe types ofglycogen storage disease that are now recognized and the main tissues affected.
Page 1 of 2 background paper on glycogen storage disease glycogen storage disease gsd is the result of defects in the processing of glycogen synthesis or breakdown within muscles, liver, and other cell types. Type i glycogen storage disease is associated with abnormalities in two genes. Possible causes include autoimmune hemolytic anemia. Glycogen storage diseases glycogen storage disease is the result of defects in the processing of glycogen synthesis or breakdown within muscles, liver, and other cell types the gsds. Most of the glycogen storage diseases follow an autosomal recessive mode of inheritence. The association for glycogen storage disease agsd was established in 1979 in order to create an organization which would be a focus for parents of and individuals with glycogen storage. Metabolic disorders glycogen storage diseases md australia. The symmetry of the enzyme is a result of its tetrameric structure. University of florida glycogen storage disease program. Glycogen storage diseases handbook association for glycogen. Glucose6phosphatase deficiency found in glycogen storage disease type i is identified as first specific enzymopathy in a hereditary disorder. Brian mcardle in 1951 after studying a young man with exercise intolerance and muscle cramps.
Glycogen storage disease type iii also known as gsdiii or cori disease is an inherited disorder caused by the buildup of a complex sugar called glycogen in the bodys cells. Ppt glycogen storage disease glycogen storage disorders authorstream ppt glycogen storage diseases glycogen storage disease. Glycogen storage disease type i nord national organization. A unique modified cornstarch product for use in the dietary management of glycogen storage disease where a long acting starch is indicated.
Background glycogen storage disease type iii is an autosomal recessive disorder that is caused by deficiencies of the glycogen debranching enzyme. Glycogen storage disease type vii or taruis disease. There are many numbered and named types, all of which are caused by deficiencies of enzymes involved in glycogen synthesis or breakdown. Gsd affects the liver, muscles and other areas of the body. The types may be divided loosely into those where the enzymic lesion, and hence the. Glycogen storage disease type vi gsd vi is a type of glycogen storage disease caused by a deficiency in liver glycogen phosphorylase or other components of the associated phosphorylase. A rendering of the human muscular form of phosphofructokinase. Re sults of the european study on glycogen storage disease t ype i. Further observations on glycogen in erythrocytes of patients with glycogenosis. To identify complications amenable to prevention in adults with glycogen storage disease gsd types ia, ib, and iii and to determine the effect of the disease on social factors. In some of the glycogen storage diseases but not all maintaining the blood glucose levels is a very central and major problem. Jun 08, 2015 glycogen storage diseases glycogen storage disease is the result of defects in the processing of glycogen synthesis or breakdown within muscles, liver, and other cell types the gsds can be divided in three main groups. The disease is due to the deficiency of glucose6phosphatase for which glycogen cannot be broken down to liberate glucose and glucose6phosphate promotes glycogen synthesis. Glycogen storage disease research david weinstein, md msc, is the worlds top researcher for glycogen storage disease gsd.
Mar 17, 2016 glycogen storage disease type vi gsd vi is a type of glycogen storage disease caused by a deficiency in liver glycogen phosphorylase or other components of the associated phosphorylase cascade system. Glycogen is a form of stored glucose that the body uses as an energy source. A potential treatment strategy for an oftenfatal inherited glycogen storage disease has been identified by researchers. Lack of hepatic glycogen synthase activity causes a. The types may be divided loosely into those where the enzymic lesion, and hence the accumulation ofpolysaccharide, are localized types i, v, vii, and those where a more generalized distribution amongst tissues is seen types ii, iii. Glycogen is the storage form of glucose in our bodies. There are many numbered and named types, all of which are caused by deficiencies of enzymes involved in glycogen synthesis or. Online mendelian inheritance in man 232200 is caused by a defect in the glucose6phosphatase system. Glycogen storage disease gsd is a condition where the body cannot release glucose from the glycogen stores due to a liver enzyme deficiency. Often, infants born with gsd iv are diagnosed with enlarged livers and failure to thrive. Glycogen storage disease gsd is a genetic condition in which the body has an enzyme problem and is not able to store or break down the complex sugar glycogen properly. Diagnosis and management of glycogen storage disease type.
A collection of disease information resources and questions answered by our genetic and rare diseases information specialists for glycogen storage disease 8. Glycogen storage diseases msd manual professional edition. This disease was the first metabolic myopathy to be recognized and was described by dr. Glycogen storage diseases types ivii differential diagnoses. Glycogen storage disease 8 genetic and rare diseases. In 3 sibs with muscle and heart glycogen deficiency, kollberg et al. Glycogen storage disease gsd involves defects that cause an abnormal accumulation of glycogen, usually found in the liver, muscle, or both. It is caused by deficient activity of the glycogen branching enzyme gbe, resulting in accumulation of abnormally formed glycogen in the liver, muscle, andor other tissues. The accumulated glycogen is structurally abnormal and impairs the function of certain organs and tissues, especially the liver and muscles. A technique for the enzymatic diagnosis of glycogen storage disease on. Patients with the disorder lack the enzyme that enables their livers to. It is presumed that the branching enzyme, amylo1,4 pdf file. Glycogen storage disease type 0 also known as gsd 0 is a condition caused by the bodys inability to form a complex sugar called glycogen, which is a major source of stored energy in the body.
Glycogen storage disease gsd is the result of defects in the processing of glycogen synthesis or breakdown within muscles, liver, and other cell types. Glycogen storage diseases, also known as glycogenoses, are genetically linked metabolic disorders that involve the enzymes regulating glycogen metabolism. A glycogen storage disease gsd, also glycogenosis and dextrinosis is a metabolic disorder. Nov 18, 2015 a potential treatment strategy for an oftenfatal inherited glycogen storage disease has been identified by researchers. Symptoms vary by the glycogen storage disease gsd type and can include muscle. Menorrhagia in patients with type i glycogen storage disease. This gsd is also inherited as an autosomal recessive trait. Often, infants born with gsd iv are diagnosed with enlarged livers and failure to thrive within their first year of life. Glycogen storage disease type ii, also called pompe disease, is an autosomal recessive metabolic disorder which damages muscle and nerve cells throughout the body.
Jun 01, 2018 glycogen storage disease type 2, also known as pompe disease or acid maltase deficiency disease, is an inherited metabolic disorder. Definition glycogen serves as the primary fuel reserve for the bodys energy needs. Glycogen storage disease type 0 genetics home reference. Mutations in the production of this enzyme are the cause of taruis disease. The diagnosis of glycogen storage disease in clinical practice. Online mendelian inheritance in man 232200 is caused by a defect in the glucose6phosphatase. Glycogen synthase deficiency glycogen storage disease type 0 presenting with hyperglycemia and glucosuria. Alonso, in pediatric gastrointestinal and liver disease fourth edition, 2011. The importance of glycogen metabolism is also highlighted by human genetic disorders that are caused by mutations in the enzymes involved. Check the full list of possible causes and conditions now.
The association for glycogen storage disease agsd was established in 1979 in order to create an organization which would be a focus for parents of and individuals with glycogen storage disease gsd to communicate, share their successes and concerns, share useful findings, provide support, create an awareness of this condition for the public, and to stimulate research in the. Glycogen storage disease type iv gsd type iv is an extremely rare condition, representing only 0. Diagnosis and management of glycogen storage disease type i. Glycogen storage diseases journal of clinical pathology. The glycogen storage diseases gsds are a group of inherited metabolic disorders that result from a defect in any one of several enzymes. Glycogen storage diseases, also known as glycogenoses, are genetically linked metabolic. The effect is profound hypoglycemia with fasting attributable to inability to make glucose by gluconeogenesis or glycogenolysis. Glycogen storage disease type 2, also known as pompe disease or acid. It is presumed that the branching enzyme, amylo1,4 pdf file must be present in all tissues. Glycogen storage disease type iii genetics home reference nih. Glycogen storage diseases definition of glycogen storage. Carrier screening to help detect the risk of having a baby with a specific inherited disorder, such as cystic fibrosis. Glycogen storage disease type 2 genetic and rare diseases. Glycogen storage diseases are carbohydrate metabolism disorders.
A technique for the enzymatic diagnosis of glycogen storage disease on very small tissue specimens. Glycogen storage disease research connecticut childrens. Glycogen storage diseases are due to either a deficiency or blockage of an enzyme that is important in converting glucose to glycogen so it can be. The hepatic glycogen storage diseases gsds are a group of disorders where abnormal storage or release of glycogen leads to potentially lifethreatening hypoglycemia and metabolic disturbances. Biochemical and clinical aspects of glycogen storage diseases.
775 551 819 1445 196 550 765 700 1608 766 953 140 1031 1081 1378 630 176 513 451 1122 552 1517 1518 1011 799 955 863 644 791 1074 713 209 323 342 770 599